VANGUARD GROUP INC - AVANOS MED INC ownership

AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 264 filers reported holding AVANOS MED INC in Q2 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AVANOS MED INC
ValueSharesWeighting
Q3 2023$110,692,530
-20.9%
5,474,408
+0.0%
0.00%0.0%
Q2 2023$139,872,550
-15.0%
5,472,322
-1.0%
0.00%
-25.0%
Q1 2023$164,466,067
+10.5%
5,530,130
+0.5%
0.00%0.0%
Q4 2022$148,830,001
+26.9%
5,500,000
+2.1%
0.00%
+33.3%
Q3 2022$117,287,000
-20.2%
5,385,078
+0.2%
0.00%
-25.0%
Q2 2022$146,997,000
-17.7%
5,376,600
+0.8%
0.00%0.0%
Q1 2022$178,700,000
-1.3%
5,334,332
+2.2%
0.00%0.0%
Q4 2021$181,040,000
+13.2%
5,221,786
+1.9%
0.00%0.0%
Q3 2021$159,874,000
-13.7%
5,124,118
+0.5%
0.00%
-20.0%
Q2 2021$185,350,000
-5.5%
5,096,248
+13.6%
0.01%0.0%
Q1 2021$196,141,000
-1.4%
4,484,264
+3.4%
0.01%
-16.7%
Q4 2020$199,023,000
+41.8%
4,337,913
+2.7%
0.01%
+20.0%
Q3 2020$140,374,000
+6.5%
4,225,600
-5.7%
0.01%0.0%
Q2 2020$131,760,000
+6.0%
4,483,128
-2.9%
0.01%0.0%
Q1 2020$124,282,000
-18.8%
4,615,045
+1.6%
0.01%0.0%
Q4 2019$153,007,000
-9.6%
4,540,262
+0.5%
0.01%
-16.7%
Q3 2019$169,272,000
-13.8%
4,518,751
+0.3%
0.01%
-14.3%
Q2 2019$196,412,000
+1.3%
4,503,839
-0.8%
0.01%
-12.5%
Q1 2019$193,827,000
-3.5%
4,541,391
+1.3%
0.01%
-11.1%
Q4 2018$200,794,000
-31.8%
4,483,007
+4.3%
0.01%
-25.0%
Q3 2018$294,519,0004,299,5270.01%
Other shareholders
AVANOS MED INC shareholders Q2 2023
NameSharesValueWeighting ↓
Paradice Investment Management LLC 3,087,229$96,322,0004.36%
RGM Capital, LLC 2,521,930$78,684,0003.86%
Tributary Capital Management, LLC 322,946$10,076,0000.78%
Alpha Paradigm Partners, LLC 52,844$1,649,000,0000.66%
HEARTLAND ADVISORS INC 307,416$9,591,0000.58%
Factorial Partners, LLC 23,400$730,0000.50%
Champlain Investment Partners, LLC 2,082,903$64,987,0000.31%
WESTWOOD HOLDINGS GROUP INC 741,503$23,135,0000.25%
Campbell & CO Investment Adviser LLC 22,100$690,0000.22%
AIGEN INVESTMENT MANAGEMENT, LP 26,488$826,0000.16%
View complete list of AVANOS MED INC shareholders